Abstract
Amentoflavone has been identified as a JAK2 inhibitor by structure-based virtual screening of a natural product library. In silico optimization using the DOLPHIN model yielded analogues with enhanced potency against JAK2 activity and HCV activity in cellulo. Molecular modeling and kinetic experiments suggested that the analogues may function as Type II inhibitors of JAK2.
Original language | English |
---|---|
Pages (from-to) | 13885-13888 |
Number of pages | 4 |
Journal | Chemical Communications |
Volume | 50 |
Issue number | 90 |
DOIs | |
Publication status | Published - 16 Oct 2014 |